Anika Therapeutics (ANIK) Sɔɔtɔ Fɔrɛkɛst
Anika Therapeutics
Nɔnyɔ nyɛ$20.40Nɔɔ 25 Gbo 2026 19:59 UTC
Nyuɛ+0.54%
AI forecast: ANIK
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The company’s hyaluronic acid-based products promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika’s product portfolio includes ORTHOVISC and HYVISC, which are used to treat osteoarthritis.
